Navigation Links
Radiation Control Technologies, Inc. Announces Exclusive License to Two Patents from the National Institutes of Health
Date:7/30/2012

ROCKVILLE, Md., July 30, 2012 /PRNewswire/ -- Radiation Control Technologies, Inc. (RCTI), a private development stage biopharmaceutical company developing RCT1938, a novel radiosensitizer that sensitizes tumor cells to killing by radiation while protecting healthy cells from radiation damage by inhibiting the synthesis of the novel target protein CD47, announced today that it has been granted an exclusive license to two patents from the National Institutes of Health (NIH).  The NIH exclusive license covers composition and uses of RCT1938 worldwide as a radiosensitizer to treat cancer and to treat or prevent radiation exposure in humans.

Radiation Control Technologies is entering into advanced preclinical testing of RCT1938 as an adjuvant for radiotherapy, as well as seeking federal grants and contracts to develop RCT1938 as radiation medical countermeasure.  RCT1938 promises to be a safe and effective adjuvant for radiotherapy for cancer and a promising medical countermeasure for acute radiation sickness and delayed effects of acute radiation exposure.  RCT1938 is derived from a chemical class that has been proven safe in clinical trials.

CD47, the novel target protein, is a "master switch" controlling key molecular pathways in tumor regression and radioprotection post-ionizing radiation.  By blocking the synthesis and expression of CD47, RCT1938 selectively sensitizes solid tumors to radiation killing and inhibits apoptosis (programmed cell death) in a comprehensive, multifactorial manner in healthy tissues.  More importantly, RCT1938 simultaneously activates natural survival pathways and triggers the cellular switch from apoptosis to survival in radiation injury in healthy cells.

Craig Liddell, Ph.D., CEO & President of RCTI, said, "Being awarded the NIH license is a key milestone for our company.  We believe RCT1938 will become the standard adjuvant for use in conjunction with cancer radiotherapy. 
'/>"/>

SOURCE Radiation Control Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. West Physics Consulting Teams with Mirion Technologies Dosimetry Services Division to Deliver Radiation Detection Services
2. Fujitsu to Showcase Radiation-Hardened RFID Using FRAM Technology at Interphex 2012 in New York City, Booth #2430
3. Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis
4. Avaxia Biologics is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation
5. ViewRay Receives FDA 510(k) Clearance for MRI-Guided Radiation Therapy System
6. Elektas Gamma Knife and Radiation Therapy Systems for Cancer Treatment Take Top Three Places in 2012s Best in KLAS for Radiation Therapy
7. Radiation Therapy in Oncology Drug Pipeline Update 2012
8. The Best Radiation Therapy Solution just got Better
9. Landauer, Inc. Appoints Peter Cempellin To President Of Landauer Radiation Measurement
10. Elekta to Showcase Revolutionary Agility Beam-shaping Innovation at Radiation Physics Annual Meeting
11. Ablation Devices Market to 2016 - (Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Cardiac, Cancer and Gynecology) - Global Market Forecast and Trends Analysis by Technology, Devices & Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... The new report by ... applications, techniques, end users and Geography) Global Size, ... - 2020," indicates that the global DNA diagnostics ... a CAGR of 9.8% from 2014 to 2020. ... effectiveness over alternative diagnostic techniques are factors which ...
(Date:8/28/2014)... Aug. 28, 2014  In recognition of the increased ... from the flu, pneumonia, shingles and other illnesses, ... declared September to be Senior Vaccination Month. Because ... is important that adults ages 65 years and ... CVS pharmacists and MinuteClinic nurse practitioners and physician ...
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire/ ... market research report is available in ... Therapeutics in Asia-Pacific Markets to 2020 ... Unmet Need in Newly Diagnosed and ... http://www.reportlinker.com/p02343492/Glioblastoma-Multiforme-Therapeutics-in-Asia-Pacific-Markets-to-2020---Novel-Therapeutic-Approaches-Target-High-Unmet-Need-in-Newly-Diagnosed-and-Recurrent-GBM.html Glioblastoma ...
Breaking Medicine Technology:DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 2Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 3Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 5Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 6Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 7Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 8Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 9
... N.J., Oct. 17 Ten abstracts providing new,analyses of ... for,MIRCERA(R) will be presented at the upcoming 40th Annual ... Francisco on November 2 - 5,2007. Among the ... PROTOS, STRIATA and RUBRA, and correction studies,including ARCTOS and ...
... MOINES, Iowa, Oct. 16 Protocol Driven ... announced a partnership,with Hallmark Insights to provide ... users of the ConXus health improvement platform. ... fulfillment services,for reward points earned by participants ...
Cached Medicine Technology:New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting 2New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting 3New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting 4PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs 2
(Date:8/29/2014)... The Fresh Diet, America’s premier gourmet meal delivery ... meal plan. Originating from The Fresh Diet’s commitment to ... designed to satisfy customers seeking a convenient, worry-free option ... to the growing demand by customers for non-meat menu ... with 14% of Americans identifying vegetarian meals as ‘more ...
(Date:8/29/2014)... PA (PRWEB) August 29, 2014 As ... Cooper City, Fla., understands that there’s a direct connection ... the knees, hips and back. "Since conventional shoe inserts ... design a solution of my own," he said. , ... Orthotic provides better support for the foot in order ...
(Date:8/29/2014)... 29, 2014 Williams Rejuva Center is ... their Latham aesthetic office. Dr. Edwin Williams, known ... the first surgeons in the area to employ the ... technique is faster and safer than similar products available ... a noninvasive procedure , designed to dramatically improve ...
(Date:8/29/2014)... Glendale Botox experts at Glenoaks Laser Center are ... of September. This special offer features 10 free units of ... can take advantage of this special offer to completely transform ... work with patients to determine if Botox or Juvederm is ... , Botox is a treatment made from the botulinum toxin. ...
(Date:8/29/2014)... Dennis Thompson HealthDay Reporter ... research performed during the early days of the Ebola outbreak ... the virus mutates and spreads. Researchers report in the ... have now determined the following: The Ebola strains ... dating back to the very first recorded outbreak of Ebola ...
Breaking Medicine News(10 mins):Health News:The Fresh Diet America's #1 At-Home Meal Delivery Company, Debuts Fresh Vegetarian Meal Plan Offering All-Natural Ingredients 2Health News:The Fresh Diet America's #1 At-Home Meal Delivery Company, Debuts Fresh Vegetarian Meal Plan Offering All-Natural Ingredients 3Health News:Williams Revjuva Center Brings Micro-Needling to Latham 2Health News:Glenoaks Laser Center is Now Offering a Special Promotion on Botox for the Month of September 2Health News:Gene Research Yields Insights Into Ebola Virus 2Health News:Gene Research Yields Insights Into Ebola Virus 3
... have observed a high resolution camera which detects tumours ... been comparing mammography with a technique called scintimammography, which ... is good at distinguishing between malignant and benign tumours, ... limitation of this kind of camera is that it ...
... to Japanese researchers, genetic abnormalities bound with marijuana-activated ... a lead researcher, of the Okayama University, observed ... use can result in schizophrenia or a considerablelly ... of the greatest mental health challenges in the ...
... looked at data for treatment of sub-arachnoid haemorrhage (SAH) in ... by bleeding into the brain do best in hospitals dealing ... within the blood supply surrounding the brain's exterior. It can ... nearly 10,000 patients admitted to 300 emergency departments was scanned, ...
... of antidepressant, called venlafaxine,assists patients with social anxiety disorder. ... and dread in relation to meeting and talking with ... situations a huge problem. Many of those with SAD ... condition can be hard to treat. ,Researchers ...
... ,According to a recent study, spending time in an Indian ... in a new study, India, looked at how traditional healing ... Muthuswamy in South India has long been a healing centre ... during a short period in 1000 were enrolled in the ...
... observed that, people suffering from heat diseases are better off ... for a few it might prove too much.People who are ... safe to enjoy a game of golf.// Researchers at the ... male golfers, aged between 50 and 75, half of whom ...
Cached Medicine News:Health News:Gene glitches connecting pot with Schizophrenia 2
4.625 inches, curved blade 4 mm....
Alvis foreign body spud 4 3/4 inches, oval curette 1 x 3 mm with fine point....
DIX foreign body spud 4 3/4 inches, 1.7 x 15 mm blade....
In reversible handle for removing foreign bodies....
Medicine Products: